Etana aims to serve patients by providing high quality, affordable and innovative biopharmaceutical products to treat a range of major medical conditions, including life-threatening cancers and metabolic, autoimmune and other major diseases. The products currently being prepared for production and commercialization or in the pipeline include the following:

RENOGEN® (epoetin alfa)
Improving the quality of life of Indonesians who are undergoing dialysis treatment

Etana is planning to start produce epoetin alfa product with RENOGEN brand name. Epoetin alfa is colony stimulating factor used to maintain red blood cell levels and to decrease the need of transfusions for anemia associated with chronic renal failure, providing hope for the increasingly large number of Indonesians undergoing dialysis treatment.

For more info, download here

BEVAGEN® (Bevacizumab Biosimilar)
An innovative, life-saving cancer treatment for Indonesian patients

Etana is also planning to start produce a Bevacizumab biosimilar product for the Indonesian market, with the brand name of BEVAGEN.  This product is used for the treatment of advanced non-small cell lung cancer and metastatic colorectal cancer. Etana will produce this drug under an out-license agreement entered into with Innovent Biologics, a world-class biopharmaceutical producer listed on the Hongkong stock exchange, and also one of Etana’s investors. Through this cooperation, Etana will be able to provide access to an innovative, life-saving drug to Indonesian patients at affordable prices.

Monoclonal Antibody Drugs (MABs)

Looking to the future, Etana expects to become the pioneer of monoclonal antibody drugs (MABs) manufacturer. Monoclonal antibodies are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance or mimic the immune system's attack on cancer cells. They are designed to bind to antigens that are generally more numerous on the surface of cancer cells than healthy cells. Monoclonal antibodies are used to treat cancer by enlisting natural immune system functions to fight the disease, with fewer side effects and greater efficacy than traditional chemotherapy.